Back to top
more

Enfusion (ENFN)

(Delayed Data from NYSE)

$9.43 USD

9.43
209,651

+0.17 (1.84%)

Updated May 15, 2024 04:00 PM ET

After-Market: $9.43 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (60 out of 250)

Industry: Internet - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Shopify (SHOP) Q1 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

Shopify's (SHOP) first-quarter 2023 results benefit from growth in merchant solutions revenues and an expanding merchant base.

Microchip (MCHP) Q4 Earnings Top Estimates, Sales Rise Y/Y

by Zacks Equity Research

Microchip's (MCHP) fourth-quarter fiscal 2023 results reflect continued momentum in the mixed-signal microcontroller business.

Apple (AAPL) Q2 Earnings Beat Estimates, Revenues Decline Y/Y

by Zacks Equity Research

Apple's (AAPL) second-quarter fiscal 2023 results benefit from strong demand for iPhone 14 amid significant forex headwind and challenging macroenvironment conditions.

Enfusion (ENFN) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Enfusion's (ENFN) first-quarter 2023 performance is expected to have benefited from healthy demand, new clients and improving margins.

Datadog (DDOG) Q1 Earnings Beat Estimates, Revenues Rise Y/Y

by Zacks Equity Research

Datadog's (DDOG) first-quarter 2023 top line benefits from customers' attraction toward new innovations.

Dolby's (DLB) Q2 Earnings & Revenues Beat Estimates, Up Y/Y

by Zacks Equity Research

Dolby's (DLB) second-quarter fiscal 2023 performance benefits from revenue growth across all business segments and increased adoption of Dolby Atmos and Dolby Vision.

TELUS (TU) Q1 Earnings Miss Estimates, Revenues Rise Y/Y

by Zacks Equity Research

TELUS's (TU) first-quarter performance gains from high service revenues in TELUS technology solutions and TELUS International.

Cirrus Logic (CRUS) Q4 Earnings Top Estimates, Down Y/Y

by Zacks Equity Research

Cirrus Logic's (CRUS) fourth-quarter fiscal 2023 performance declines due to lower general market sales and reduced smartphone sales.

ANSYS (ANSS) Q1 Earnings & Revenues Beat Estimates, Up Y/Y

by Zacks Equity Research

ANSYS's (ANSS) first-quarter performance benefits from strength in the aerospace and defense, high-tech and automotive sectors

Watts Water (WTS) Q1 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

Watts Water's (WTS) first-quarter performance improves due to momentum across APMEA and the Americas amid rising inflation.

CDW's Q1 Earnings & Revenues Surpass Estimates, Down Y/Y

by Zacks Equity Research

CDW's first-quarter 2023 performance is affected due to weakness across all business segments and weakening IT spending.

Lumen (LUMN) Q1 Earnings Miss Estimates, Revenues Down Y/Y

by Zacks Equity Research

Lumen's (LUMN) first-quarter 2023 performance is affected by the completion of the sale of its Latin America business and its 20-state ILEC business to Apollo.

Enfusion, Inc. (ENFN) Flat As Market Sinks: What You Should Know

by Zacks Equity Research

In the latest trading session, Enfusion, Inc. (ENFN) closed at $8.56, marking no change from the previous day.

Enfusion, Inc. (ENFN) Q1 Earnings Preview: What's in the Cards?

by Zacks Equity Research

Enfusion, Inc. (ENFN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SNAP's Q1 Earnings Increase Y/Y, Revenues Miss Estimates

by Zacks Equity Research

SNAP's first-quarter 2023 results reflect steady user growth and an increase in Snapchat+ users amid a fall in average revenues per user.

Bears are Losing Control Over Enfusion, Inc. (ENFN), Here's Why It's a 'Buy' Now

by Zacks Equity Research

Enfusion, Inc. (ENFN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Enfusion, Inc. (ENFN) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Enfusion, Inc. (ENFN) closed at $8.74, marking a +0.69% move from the previous day.

After Plunging -14.72% in 4 Weeks, Here's Why the Trend Might Reverse for Enfusion, Inc. (ENFN)

by Zacks Equity Research

Enfusion, Inc. (ENFN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Best Momentum Stock to Buy for March 29th

by Zacks Equity Research

NUE, ENFN and TRIN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 29, 2023.

Enfusion, Inc. (ENFN) Q4 Earnings Match Estimates

by Zacks Equity Research

Enfusion, Inc. (ENFN) delivered earnings and revenue surprises of 0% and 1.60%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Sweta Killa headshot

5 Stocks to Pop Surprise Returns From Secret Santa

by Sweta Killa

Adicet Bio (ACET), Enfusion (ENFN), Dillard's (DDS), First BanCorp. (FBP) and Hillenbrand (HI) could bring gifts of surprise returns from Secret Santa.